Results 141 to 150 of about 764,021 (214)

Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance [PDF]

, 2012
Giulia Paolella, Pasquale Pisano, Raffaele Albano, Lucio Cannaviello, Carolina Saori Ishii Mauro, Gabriella Esposito, Pietro Vajro   +6 more
openalex   +1 more source

Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk. [PDF]

Cureus
Bhatt NK, Agarwal Y, Neelakantan Ramaswamy S, Bendagiri Matam M, Harikrishnan S, Chand S, Bhatt H, Malasevskaia I.   +7 more
europepmc   +1 more source

Effect and mechanism of fisetin against the development of metabolic dysfunction-associated fatty liver disease. [PDF]

Sci Rep
Peng X, Wei Z, Liu S, Liu L, Jiang H, Yu L, Xu X, Gu Z.   +7 more
europepmc   +1 more source

Fatty liver formation in patients with breast cancer on tamoxifen therapy in Iraqi female

, 2022
Israa Jarjees Rasheed Saeed, Oday Abdulhadi Jassim, Marwah Adel Mahdi   +2 more
openalex   +2 more sources

Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids [PDF]

, 2017
Abumrad, Nada A., al, et, Cifarelli, Vincenza   +2 more
core   +2 more sources

Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease. [PDF]

World J Hepatol
Vargas-Vargas MA, González-Montoya M, Torres-Isidro O, Ortiz-Avila O, Calderón-Cortés E, Cortés-Rojo C.   +5 more
europepmc   +1 more source

The causal relationship between non-alcoholic fatty liver disease, hypertension, and cardiovascular diseases: implications for future research [PDF]

Toshiki Maeda
openalex   +1 more source

Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial. [PDF]

J Taibah Univ Med Sci
Taha BO, Kobeisy MA, Abdelmohsen E, Abdelrhman T, Abokresha MM, Hassanein ZM, AbdEllah-Alawi MHM.   +6 more
europepmc   +1 more source

Hepatic Mechanisms of Myocardial Infarction: A New Perspective in Metabolic Dysfunction-Associated Fatty Liver Disease. [PDF]

J Am Heart Assoc
Cui J, Wang W, Xu Q, Zhu M, Li Y, Liu Y, Liu Y.   +6 more
europepmc   +1 more source

Different dietary fatty acids have dissimilar effects on activity and gene expression of mitochondrial tricarboxylate carrier in rat liver

, 2004
Luisa Siculella, Simona Sabetta, Fabrizio Damiano, Anna Maria Giudetti, Gabriele V. Gnoni   +4 more
openalex   +2 more sources